Plasma microRNAs and Inflammation in Schizophrenia
Author Information
Author(s): Takuya Miyano, Masakazu Hirouchi, Naoki Yoshimura, Kotaro Hattori, Tsuyoshi Mikkaichi, Naoki Kiyosawa
Primary Institution: Daiichi Sankyo Co., Ltd.
Hypothesis
The study aims to verify the reproducibility of miRNA-based patient stratification and explore pathophysiological pathways linked to symptoms using plasma miRNAs.
Conclusion
Plasma miRNAs are potential biomarkers for identifying patient subgroups and investigating symptom-related molecular mechanisms in schizophrenia.
Supporting Evidence
- Plasma miRNAs reproducibly stratified schizophrenia patients into three subgroups.
- Symptom-related miRNAs were associated with inflammation.
- Patients with high PANSS scores had high levels of inflammatory cytokines.
Takeaway
This study found that certain tiny molecules in the blood can help doctors understand different types of schizophrenia and how they relate to inflammation.
Methodology
The study measured levels of 376 miRNAs in plasma samples of schizophrenia patients and obtained their PANSS and BACS scores.
Potential Biases
Uncontrolled variables such as treatment history and demographic factors may affect results.
Limitations
The sample size and diversity may be insufficient to generalize findings, and the study only analyzed miRNA expression at one time point per subject.
Participant Demographics
All participants were Japanese schizophrenia patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website